Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDH1 | O75874 | 19/20 | 0.45 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | IDH2 | P48735 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18766930 | 0.81 | HRH4 (0.44) | IDH1HRH4HRH3 | |
| SCHEMBL18766880 | 0.79 | HRH4 (0.47) | IDH1HRH4HRH3 | |
| SCHEMBL17149861 | 0.77 | ALOX15 (0.51) | HRH4HRH3 | |
| SCHEMBL20825684 | 0.71 | HRH4 (0.45) | IDH1HRH4HRH3 | |
| SCHEMBL20825908 | 0.70 | IDH1 (0.39) | IDH1HRH4 | |
| SCHEMBL18766993 | 0.70 | HRH4 (0.55) | HRH4HRH3 | |
| SCHEMBL18766989 | 0.69 | HRH4 (0.47) | IDH1HRH4HRH3 | |
| SCHEMBL1253868 | 0.68 | HRH4 (0.47) | IDH1HRH4HRH3 | |
| SCHEMBL18766968 | 0.68 | TP53 (0.43) | — | |
| SCHEMBL5103790 | 0.68 | LOXL2 (0.50) | IDH1HRH4HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10167257-B2 | Indole derivatives for use in medicine | IOMET PHARMA LTD. (GB) | 2019-01-01 | — | — | US | disclosed |
| US-20170107178-A1 | INDOLE DERIVATIVES FOR USE IN MEDICINE | IOMET PHARMA LTD. (GB) | 2017-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10167257-B2 | Indole derivatives for use in medicine | IDO1, IDO2, TDO2 | IDH1 242/4885HRH4 67/4885HRH3 111/4885 |
| US-20170107178-A1 | INDOLE DERIVATIVES FOR USE IN MEDICINE | IDO1, IDO2, TDO2 | IDH1 242/4885HRH4 67/4885HRH3 111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.